Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine novartis.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novartis.com Daily Mail and Mail on Sunday newspapers.
Novartis has agreed to
expand its fill-and-finish support for the Pfizer/BioNTech
COVID-19 vaccine by using manufacturing
facilities Ljubljana, Slovenia, to fill at least 24 million
doses in 2022, the. | October 21, 2021
Novartis has signed a new initial agreement with BioNTech for COVID-19 vaccine manufacturing: with its sterile manufacturing facilities in Ljubljana, Slovenia, to fill at least 24 million doses in 2022.